Rocket Pharmaceuticals names Joseph Manhede as principal accounting officer

Rocket Pharmaceuticals disclosed in an 8-K filing that John Militello informed the company on June 24, 2026 of his resignation as VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer, effective July 7, 2026, to pursue other opportunities.¹

To fill the role, Joseph Manhede, the company's Associate Vice President, Corporate Controller, was appointed as Principal Accounting Officer effective July 8, 2026.¹ Manhede, age 48, has served as the company's Associate Vice President, Corporate Controller since April 2026.¹

Before joining Rocket, Manhede was Vice President and Financial Controller for Outlook Therapeutics, a clinical-stage biopharmaceutical company, where he handled accounting and finance functions including financial reporting, SEC compliance, internal controls, budgeting, and strategic financial planning, along with supporting financing transactions and corporate governance initiatives.¹ Earlier in his career, he held senior finance and accounting positions at Amneal Pharmaceuticals, Unilife Corporation, and Celator Pharmaceuticals, Inc., serving as Corporate Controller and contributing to financial reporting, IPO readiness, SOX compliance, and acquisition integration.¹ He began his career at Deloitte, where he served as an Audit Manager.¹ Manhede is a Certified Public Accountant and holds an MBA from Holy Family University.¹

The filing states that no new compensatory arrangements will be entered into with Manhede in connection with his new role.¹ It also notes that there are no family relationships between Manhede and any other director or executive officer of the company, and no transactions involving him requiring disclosure under Item 404(a) of Regulation S-K.¹